<DOC>
	<DOCNO>NCT01893450</DOCNO>
	<brief_summary>Autoimmune ophthalmopathy clinically evident one third Graves ' disease case . In case mild ; however , 3 5 % case severe presentation . At present , treatment direct identify vision threaten require aggressive intervention , usually glucocorticoid . For mild case treatment limited normalization hyperthyroidism support measure . Preliminary data show pentoxifylline bromocriptine may favorable effect course ophthalmopathy inhibition synthesis TNF-α , VEGF , glycosaminoglycan production , lymphocyte infiltration . Therefore , aim study evaluate effect bromocriptine pentoxifylline clinical course quality life patient mild moderate ophthalmopathy associate Graves´disease . Methods . Patients mild moderate ophthalmopathy , less one year evolution , naive treatment randomize receive treatment 12 month either 1 ) bromocriptine ( 5 mg twice day ) + methimazole ( 30 mg/day ) , 2 ) pentoxifylline ( 400 mg twice day ) + methimazole ( 30 mg/day ) , 3 ) methimazole ( 30 mg/day ) . They complete 10 visit evaluate proptosis clinical activity score ( CAS ) . In addition , first last visit quality life questionnaire specific Graves ' ophthalmopathy ( GO-QOL ) apply .</brief_summary>
	<brief_title>Bromocriptine Pentoxifylline Ophthalmopathy Autoimmune Treatment</brief_title>
	<detailed_description />
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Graves Ophthalmopathy</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<mesh_term>Bromocriptine</mesh_term>
	<criteria>Women men Between 18 45 year Autoimmune hyperthyroidism one year le evolution No previous treatment Mild moderate ophthalmopathy Smoking Severe ophthalmopathy Steroid treatment Asthma Diabetes significant disease Creatine &gt; 1.5 mg/dl Women child bear potential use birth control method Opthalmologic diseases Uncontrolled hypertension History ischemic cardiopathy History stroke History gastrointestinal bleeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Graves ophthalmopathy</keyword>
	<keyword>Exophthalmos</keyword>
	<keyword>Proptosis</keyword>
	<keyword>Quality life</keyword>
</DOC>